. 2015 Dec 8;5:17914. doi: 10.1038/srep17914

Table 6. Summary of outcomes of the three studies evaluating individualized preformed implants.

Study	% of patients experiencing residual diplopia	Enophthalmos	Complications
Nkenke²²	N/A	Reduction in Enophthalmos (mm) ± SD Assisted: 3.25 ± 1.44 Control: 3.88 ± 1.23 (p = 0.31)	Assisted: 1 reduced vision, 2 suspected retrobulbar hematoma Control: 2 suspected retrobulbar hematoma (p = N.S.)
Scolozzi²³	N/A	Reduction in Enophthalmos (mm) ± SD Assisted: 1.5 ± 1.58 Control: 1.8 ± 1.61 (p = 0.79)	N/A
Guo²⁴	Assisted: 17% Control: 88% (p = 0.0042)	Assisted: 21%* Control: 50%* (p = 0.04)*	N/A

N/A = not available; N.S. = non-significant; *percentage of patients having residual enophthalmos; *exophthalmometry data not reported; SD = standard deviation.